Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

4.20
Delayed Data
As of Jan 23
 +0.08 / +1.94%
Today’s Change
2.17
Today|||52-Week Range
7.67
+12.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.00500.0K
 
 
Depreciation And Amortization34.5K43.4K45.7K38.0K
 
 
 
 
 
 
Operating ExpensesGross Income-34.5K-43.4K-45.7K--
 
 
 
 
General Expenses20.4M18.6M18.6M35.8M
 
 
 
 
 
Research And Development11.8M11.4M11.4M19.9M
 
 
 
 
 
Total Operating Expenses20.4M18.7M18.7M35.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.4M-18.7M-18.7M-35.3M
 
 
 
 
 
Extraordinary Credit65.0K886.1K0.000.00
 
 
 
Extraordinary Charge0.00-600.0K-157.5K-29.4K
 
 
 
 
Other Expenses100.4K321.6K424.7K1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.2M-18.1M-18.4M-34.0M
 
 
 
 
 
Net Income-20.2M-18.1M-18.4M-34.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS80.9M82.9M85.8M102.6M
 
 
 
 
 
Shares To Calculate EPS Diluted80.9M82.9M85.8M102.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.22-$0.21-$0.33
 
 
 
 
 
EPS Diluted-$0.25-$0.22-$0.21-$0.33